World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

AUDIT OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Dr. Anum Yaseen*, Dr. Anfal Ijaz and Dr. Mehak Khadim

ABSTRACT

Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation that is usually progressive resulting from exposure to noxious stimuli or gases. Additionally, exacerbations and comorbidities contribute to the overall severity in the individual patient. Objective: The objective of this study was to assess the frequency of metabolic syndrome in patients with chronic obstructive pulmonary disease. Material and Methods: This study was conducted in Department of Medicine Bahawalpur Victoria Hospital during August 2018 to August 2019. This is a cross sectional study which include 148 patients, who were presented with COPD in the hospital. After approval from ethical committee all the parents were informed for the purpose of the study and a written informed consent was taken from the patients. Their Waist Circumference, Glucose Level (mg/dL), Triglyceride level (mg/dL), High Density Lipoprotein level (mg/dL), Systolic & diastolic blood pressure was measured for the diagnosis of metabolic syndrome. Effect modifiers like age, gender and BMI were addressed through stratification of data. All the data was collected through a well-defined Performa. Results: From 148 patients, it was observed that the minimum age was 36 years and maximum age was 65 years with mean and standard deviation of the age was 52.44 ± 7.83 years. The minimum waist circumference was 70 cm and maximum was 114 cm with mean and standard deviation was 90.24 ± 13.80cm. The minimum glucose level was 80 mg/dL and maximum was 115 mg/dL with mean and standard deviation was 94.05 ± 11.15 mg/dL. Conclusion: The frequency of metabolic syndrome was found in 43.9% patients with chronic obstructive pulmonary disease. All effect modifiers have significant influence.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR